EP2753363A4 - Compositions comprenant le mg53 et procédés de traitement et de prévention de lésions au niveau des voies respiratoires - Google Patents

Compositions comprenant le mg53 et procédés de traitement et de prévention de lésions au niveau des voies respiratoires

Info

Publication number
EP2753363A4
EP2753363A4 EP12829354.5A EP12829354A EP2753363A4 EP 2753363 A4 EP2753363 A4 EP 2753363A4 EP 12829354 A EP12829354 A EP 12829354A EP 2753363 A4 EP2753363 A4 EP 2753363A4
Authority
EP
European Patent Office
Prior art keywords
prevention
compositions
treatment
methods
airway injury
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP12829354.5A
Other languages
German (de)
English (en)
Other versions
EP2753363A2 (fr
Inventor
Jianjie Ma
Noah Weisleder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Medicine and Dentistry of New Jersey
Rutgers State University of New Jersey
Original Assignee
University of Medicine and Dentistry of New Jersey
Rutgers State University of New Jersey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Medicine and Dentistry of New Jersey, Rutgers State University of New Jersey filed Critical University of Medicine and Dentistry of New Jersey
Publication of EP2753363A2 publication Critical patent/EP2753363A2/fr
Publication of EP2753363A4 publication Critical patent/EP2753363A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP12829354.5A 2011-09-07 2012-09-06 Compositions comprenant le mg53 et procédés de traitement et de prévention de lésions au niveau des voies respiratoires Withdrawn EP2753363A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161531708P 2011-09-07 2011-09-07
PCT/US2012/053920 WO2013036610A2 (fr) 2011-09-07 2012-09-06 Compositions comprenant le mg53 et procédés de traitement et de prévention de lésions au niveau des voies respiratoires

Publications (2)

Publication Number Publication Date
EP2753363A2 EP2753363A2 (fr) 2014-07-16
EP2753363A4 true EP2753363A4 (fr) 2015-03-11

Family

ID=47832768

Family Applications (1)

Application Number Title Priority Date Filing Date
EP12829354.5A Withdrawn EP2753363A4 (fr) 2011-09-07 2012-09-06 Compositions comprenant le mg53 et procédés de traitement et de prévention de lésions au niveau des voies respiratoires

Country Status (3)

Country Link
EP (1) EP2753363A4 (fr)
CN (1) CN104066452A (fr)
WO (1) WO2013036610A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107266551B (zh) * 2016-04-06 2021-03-05 牡丹江友搏药业有限责任公司 一种mg53突变体及其制备方法和应用
KR102483242B1 (ko) * 2016-08-01 2022-12-29 호프 메디신 (난징) 씨오., 엘티디. Mg53 돌연변이체, 및 그의 제조 방법 및 그의 용도
CN107987147B (zh) * 2016-10-26 2024-07-05 牡丹江友搏药业有限责任公司 一种mg53多聚体制备方法及其用途
WO2018170796A1 (fr) * 2017-03-22 2018-09-27 Tsinghua University Trim72 en tant que cible thérapeutique potentielle pour la sla par l'ubiquitination de la protéine fus mutante
CN107629123B (zh) * 2017-09-07 2020-08-25 北京大学 一种抗mg53蛋白的纳米抗体及应用
CN113474011A (zh) * 2018-12-07 2021-10-01 俄亥俄州立创新基金会 促进角膜组织修复的组合物和方法
EP4003388A4 (fr) * 2019-07-25 2024-05-22 Ohio State Innovation Foundation Composition et procédé pour améliorer la performance tissulaire
WO2021211098A1 (fr) * 2020-04-14 2021-10-21 Trim-Edicine, Inc. Prévention et traitement d'une défaillance d'organe induite par une infection virale

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008054561A2 (fr) * 2006-07-11 2008-05-08 University Of Medicine And Dentistry Of New Jersey Protéines, acides nucléiques encodant celles-ci et leurs procédés d'utilisation associés
WO2009073808A2 (fr) * 2007-12-04 2009-06-11 University Of Medicine And Dentistry Of New Jersey Compositions et procédés de modulation du recollage de membranes cellulaires

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003214944A1 (en) * 2002-01-31 2003-09-02 Baylor College Of Medicine Secreted caveolin as a marker for prostate cancer
US20110202033A1 (en) * 2006-07-11 2011-08-18 Noah Weisleder Compositions and methods for the treatment and prevention of cardiac ischemic injury
US8058227B2 (en) * 2006-10-03 2011-11-15 Medical University Of South Carolina Method of treating fibrosis in a subject in need thereof comprising administering a composition comprising a CSD
CN101797375B (zh) * 2009-12-02 2013-01-23 北京大学 Mg53蛋白预防和/或治疗心脏缺血/再灌损伤的用途

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008054561A2 (fr) * 2006-07-11 2008-05-08 University Of Medicine And Dentistry Of New Jersey Protéines, acides nucléiques encodant celles-ci et leurs procédés d'utilisation associés
WO2009073808A2 (fr) * 2007-12-04 2009-06-11 University Of Medicine And Dentistry Of New Jersey Compositions et procédés de modulation du recollage de membranes cellulaires

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CAI CHUANXI ET AL: "MG53 nucleates assembly of cell membrane repair machinery", NATURE CELL BIOLOGY, MACMILLAN MAGAZINES LTD, vol. 11, no. 1, 1 January 2009 (2009-01-01), pages 56 - 64,1, XP002562736, ISSN: 1465-7392, [retrieved on 20081130], DOI: 10.1038/NCB1812 *
JIA YANLIN ET AL: "Treatment of acute lung injury by targeting MG53-mediated cell membrane repair.", NATURE COMMUNICATIONS 2014, vol. 5, 2014, pages 4387, XP002734684, ISSN: 2041-1723 *
LING RONG ET AL: "Panax notoginseng saponins attenuate acute lung injury induced by intestinal ischaemia/reperfusion in rats", RESPIROLOGY, vol. 14, no. 6, 1 August 2009 (2009-08-01), pages 890 - 898, XP055380261, ISSN: 1323-7799, DOI: 10.1111/j.1440-1843.2009.01586.x *

Also Published As

Publication number Publication date
EP2753363A2 (fr) 2014-07-16
WO2013036610A3 (fr) 2013-05-02
CN104066452A (zh) 2014-09-24
WO2013036610A2 (fr) 2013-03-14

Similar Documents

Publication Publication Date Title
IL266582A (en) Preparations and methods for the treatment of hemoglobin diseases
HK1209788A1 (en) Methods and compositions for the treatment of lysosomal storage diseases
HK1202416A1 (en) Compositions and methods for preventing and treating oral diseases
IL225471A0 (en) Preparations and methods for the prevention and treatment of cancer
EP2847152A4 (fr) Compositions et méthodes de traitement du syndrome métabolique
EP2603202A4 (fr) Compositions et méthodes pour traiter une tauopathie
EP2736528A4 (fr) Compositions et méthodes de traitement du vih
EP2665433A4 (fr) Dispositifs et procédés de traitement de tissus
EP2771030A4 (fr) Compositions et méthodes de traitement de protéinopathies
EP2688594A4 (fr) Procédés et compositions pour le traitement du cancer
EP2696874A4 (fr) Compositions et méthodes utilisées de traitement d'affections nasales
GB2503066B8 (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
EP2753363A4 (fr) Compositions comprenant le mg53 et procédés de traitement et de prévention de lésions au niveau des voies respiratoires
PL2701645T3 (pl) Urządzenie do leczenia i/lub zapobiegania chorobom rogówki
EP2558085A4 (fr) Compositions et procédés pour la prévention et le traitement du cancer
IL225793A0 (en) Methods and preparations for curing insulin-related medical conditions
ZA201408055B (en) Compositions and methods for the treatment of local pain
HK1211221A1 (en) Formulations for the treatment and prevention of obesity
EP2675275A4 (fr) Compositions et méthodes utilisables en vue du traitement de l'obésité et des troubles associés
EP2575824A4 (fr) Procédés pour le traitement et la prévention de maladies inflammatoires
EP2709632A4 (fr) Compositions et procédés pour le traitement de maladies de la peau
ZA201408062B (en) Compositions and methods for the treatment of multiple sclerosis
ZA201408058B (en) Compositions and methods for the treatment of epilepsy
ZA201408065B (en) Compositions and methods for the treatment of diabetes
EP3603631C0 (fr) Procédé et compositions pour le traitement d'une diverticulose

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20140403

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: C07K 14/47 20060101ALI20150127BHEP

Ipc: A61P 9/00 20060101ALI20150127BHEP

Ipc: A61K 31/7088 20060101ALI20150127BHEP

Ipc: A61K 31/105 20060101ALI20150127BHEP

Ipc: A61K 48/00 20060101AFI20150127BHEP

Ipc: A61P 11/00 20060101ALI20150127BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20150209

17Q First examination report despatched

Effective date: 20160614

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20171027